Aktiespararna women’s event to feature Dignitana CEO Catarina Mård Löwenadler

Files for download
Dignitana Release - wkr0006.pdf

Dignitana CEO Catarina Mård Löwenadler will speak at the Aktiespararna Women’s Evening on 18 October 2022 in Stockholm. Ms. Löwenadler’s 20-minute presentation begins at 1700 CET and will be streamed live. Event attendees will have the opportunity to ask questions following her presentation.

“Dignitana is committed to ensuring that every single cancer patient can maintain dignity and quality of life during and after cancer treatment. Currently 87 percent of our customers are women, so having the opportunity to deliver our message specifically to female investors allows us to really focus on what we know matters to women – both as patients, and as investors in MedTech,” said Catarina Mård Löwenadler.

The event is hosted by Aktiespararna, an independent organization working in the interest of private individuals who invest in stocks, mutual funds and other stock-related securities. With only women on stage and in the audience for this special event, Aktiespararna is inspiring more women to become active in their share saving and build networks of like-minded people. The organization has more than 70,000 members and is a member of the World Federation of Investors which encompasses investors' organizations in 20 countries representing approximately 500,000 stock market investors.

You can stream the event live  on the Aktiespararna  YouTube channel  or  aktiespararna.se/tv/live. Beginning the following day the program will be published as a video on YouTube and at  aktiespararna.se/tv/evenagen .

Attendance to the event is free but space is limited so interested attendees may register here.  The audience may submit questions via SMS 079 347 98 45  or in the live chat connected to the video player.

For More Information Contact 

Melissa Bourestom, Chief Communications Officer,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com